» Articles » PMID: 33552965

SurvNet: A Novel Deep Neural Network for Lung Cancer Survival Analysis With Missing Values

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Feb 8
PMID 33552965
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Survival analysis is important for guiding further treatment and improving lung cancer prognosis. It is a challenging task because of the poor distinguishability of features and the missing values in practice. A novel multi-task based neural network, SurvNet, is proposed in this paper. The proposed SurvNet model is trained in a multi-task learning framework to jointly learn across three related tasks: input reconstruction, survival classification, and Cox regression. It uses an input reconstruction mechanism cooperating with incomplete-aware reconstruction loss for latent feature learning of incomplete data with missing values. Besides, the SurvNet model introduces a context gating mechanism to bridge the gap between survival classification and Cox regression. A new real-world dataset of 1,137 patients with IB-IIA stage non-small cell lung cancer is collected to evaluate the performance of the SurvNet model. The proposed SurvNet achieves a higher concordance index than the traditional Cox model and Cox-Net. The difference between high-risk and low-risk groups obtained by SurvNet is more significant than that of high-risk and low-risk groups obtained by the other models. Moreover, the SurvNet outperforms the other models even though the input data is randomly cropped and it achieves better generalization performance on the Surveillance, Epidemiology, and End Results Program (SEER) dataset.

Citing Articles

Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.

Rustandi T, Yumassik A, Ilahi F, Alfian R, Prihandiwati E, Susanto Y Front Pharmacol. 2024; 15:1428755.

PMID: 38994207 PMC: 11236599. DOI: 10.3389/fphar.2024.1428755.


Application of machine learning for lung cancer survival prognostication-A systematic review and meta-analysis.

Didier A, Nigro A, Noori Z, Omballi M, Pappada S, Hamouda D Front Artif Intell. 2024; 7:1365777.

PMID: 38646415 PMC: 11026647. DOI: 10.3389/frai.2024.1365777.


PiDeeL: metabolic pathway-informed deep learning model for survival analysis and pathological classification of gliomas.

Kaynar G, Cakmakci D, Bund C, Todeschi J, Namer I, Cicek A Bioinformatics. 2023; 39(11).

PMID: 37952175 PMC: 10663986. DOI: 10.1093/bioinformatics/btad684.


Survival Mixture Density Networks.

Han X, Goldstein M, Ranganath R Proc Mach Learn Res. 2023; 182:224-248.

PMID: 37706207 PMC: 10498417.


Interpretable deep learning for improving cancer patient survival based on personal transcriptomes.

Sun B, Chen L Sci Rep. 2023; 13(1):11344.

PMID: 37443344 PMC: 10344908. DOI: 10.1038/s41598-023-38429-7.


References
1.
Kalderstam J, Eden P, Bendahl P, Strand C, Ferno M, Ohlsson M . Training artificial neural networks directly on the concordance index for censored data using genetic algorithms. Artif Intell Med. 2013; 58(2):125-32. DOI: 10.1016/j.artmed.2013.03.001. View

2.
Kim S, Park T, Kon M . Cancer survival classification using integrated data sets and intermediate information. Artif Intell Med. 2014; 62(1):23-31. DOI: 10.1016/j.artmed.2014.06.003. View

3.
Wang J, Zhang L, Chen Y, Yi Z . A New Delay Connection for Long Short-Term Memory Networks. Int J Neural Syst. 2018; 28(6):1750061. DOI: 10.1142/S0129065717500617. View

4.
Silver D, Schrittwieser J, Simonyan K, Antonoglou I, Huang A, Guez A . Mastering the game of Go without human knowledge. Nature. 2017; 550(7676):354-359. DOI: 10.1038/nature24270. View

5.
Detterbeck F, Boffa D, Kim A, Tanoue L . The Eighth Edition Lung Cancer Stage Classification. Chest. 2016; 151(1):193-203. DOI: 10.1016/j.chest.2016.10.010. View